NCT03635294View on ClinicalTrials.gov

Multi-Omics and IPSCs to Improve Diagnosis of Rare Intellectual Disabilities

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 9, 2019

Primary Completion Date

February 11, 2020

Study Completion Date

February 11, 2020

Conditions
Rare Intellectual Disabilities
Interventions
OTHER

Blood sample

combining genomics, transcriptomics, metabolomics and morphological analyses performed on induced pluripotent stem cell (iPSC)-derived neural cells

Trial Locations (6)

Unknown

CHU Angers, Angers

HCL Lyon, Bron

CHU de Bourgogne, Dijon

CHU Nantes, Nantes

CHU Poitiers, Poitiers

CHU Rennes, Rennes

All Listed Sponsors
lead

University Hospital, Angers

OTHER_GOV

NCT03635294 - Multi-Omics and IPSCs to Improve Diagnosis of Rare Intellectual Disabilities | Biotech Hunter | Biotech Hunter